APO Research

APO RESEARCH · REPORT

Pipeline Embolization Device (PED)

Selected research

Industry Growth & Trends

Global Pipeline Embolization Device (PED) Industry Growth and Trends Forecast to 2032

Market perspective

The global Pipeline Embolization Device (PED) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pipeline Embolization Device (PED) include Ascendis Health, Balt Extrusion, Boston Scientific, Codman, Evasc, Microvention, Phenox GmbH, Accumedical and ZYLOX-TONBRIDGE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pipeline Embolization Device (PED) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pipeline Embolization Device (PED) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pipeline Embolization Device (PED) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pipeline Embolization Device (PED).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pipeline Embolization Device (PED) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pipeline Embolization Device (PED) Market by Company

Ascendis Health

Balt Extrusion

Boston Scientific

Codman

Evasc

Microvention

Phenox GmbH

Accumedical

ZYLOX-TONBRIDGE

Medtronic

Johnson & Johnson

Stryker Corporation

MicroPort

Pipeline Embolization Device (PED) Segment by Type

48 Alloy Wire Braided

64 Alloy Wire Braided

Other

Pipeline Embolization Device (PED) Segment by Application

Intracranial Aneurysm Treatment

Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)

Other

Pipeline Embolization Device (PED) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pipeline Embolization Device (PED) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pipeline Embolization Device (PED) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pipeline Embolization Device (PED).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pipeline Embolization Device (PED) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pipeline Embolization Device (PED) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 48 Alloy Wire Braided Table 2. Major Company of 64 Alloy Wire Braided Table 3. Major Company of Other Table 4. Global Pipeline Embolization Device (PED) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 6. Global Pipeline Embolization Device (PED) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pipeline Embolization Device (PED) Sales Market Share in Value by Type (2021-2026) Table 9. Global Pipeline Embolization Device (PED) Price by Type (2021-2026) & (USD/unit) Table 10. Global Pipeline Embolization Device (PED) Sales by Type (2027-2032) & (k units) Table 11. Global Pipeline Embolization Device (PED) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pipeline Embolization Device (PED) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pipeline Embolization Device (PED) Sales Market Share in Value by Type (2027-2032) Table 14. Global Pipeline Embolization Device (PED) Price by Type (2027-2032) & (USD/unit) Table 15. North America Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 16. North America Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 18. Europe Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 22. Latin America Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (US$ Million) Table 25. Pipeline Embolization Device (PED) Industry Trends Table 26. Pipeline Embolization Device (PED) Industry Drivers Table 27. Pipeline Embolization Device (PED) Industry Opportunities and Challenges Table 28. Pipeline Embolization Device (PED) Industry Restraints Table 29. Global Pipeline Embolization Device (PED) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pipeline Embolization Device (PED) Revenue Market Share by Company (2021-2026) Table 31. Global Pipeline Embolization Device (PED) Sales by Company (2021-2026) & (k units) Table 32. Global Pipeline Embolization Device (PED) Sales Share by Company (2021-2026) Table 33. Global Pipeline Embolization Device (PED) Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Pipeline Embolization Device (PED) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pipeline Embolization Device (PED) Major Company Production Sites and Headquarters Table 36. Global Pipeline Embolization Device (PED) Company, Product Type & Application Table 37. Global Pipeline Embolization Device (PED) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pipeline Embolization Device (PED) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pipeline Embolization Device (PED) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pipeline Embolization Device (PED) Sales by Region (2021-2026) & (k units) Table 42. Global Pipeline Embolization Device (PED) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pipeline Embolization Device (PED) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pipeline Embolization Device (PED) Sales Market Share in Value by Region (2021-2026) Table 45. Global Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Pipeline Embolization Device (PED) Sales by Region (2027-2032) & (k units) Table 47. Global Pipeline Embolization Device (PED) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pipeline Embolization Device (PED) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pipeline Embolization Device (PED) Sales Market Share in Value by Region (2027-2032) Table 50. Global Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Pipeline Embolization Device (PED) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 53. Global Pipeline Embolization Device (PED) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pipeline Embolization Device (PED) Sales Market Share in Value by Application (2021-2026) Table 56. Global Pipeline Embolization Device (PED) Price by Application (2021-2026) & (USD/unit) Table 57. Global Pipeline Embolization Device (PED) Sales by Application (2027-2032) & (k units) Table 58. Global Pipeline Embolization Device (PED) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pipeline Embolization Device (PED) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pipeline Embolization Device (PED) Sales Market Share in Value by Application (2027-2032) Table 61. Global Pipeline Embolization Device (PED) Price by Application (2027-2032) & (USD/unit) Table 62. North America Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 63. North America Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 65. Europe Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 69. Latin America Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (US$ Million) Table 72. Ascendis Health Company Information Table 73. Ascendis Health Business Overview Table 74. Ascendis Health Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Ascendis Health Pipeline Embolization Device (PED) Product Portfolio Table 76. Ascendis Health Recent Development Table 77. Balt Extrusion Company Information Table 78. Balt Extrusion Business Overview Table 79. Balt Extrusion Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio Table 81. Balt Extrusion Recent Development Table 82. Boston Scientific Company Information Table 83. Boston Scientific Business Overview Table 84. Boston Scientific Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Boston Scientific Pipeline Embolization Device (PED) Product Portfolio Table 86. Boston Scientific Recent Development Table 87. Codman Company Information Table 88. Codman Business Overview Table 89. Codman Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Codman Pipeline Embolization Device (PED) Product Portfolio Table 91. Codman Recent Development Table 92. Evasc Company Information Table 93. Evasc Business Overview Table 94. Evasc Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Evasc Pipeline Embolization Device (PED) Product Portfolio Table 96. Evasc Recent Development Table 97. Microvention Company Information Table 98. Microvention Business Overview Table 99. Microvention Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Microvention Pipeline Embolization Device (PED) Product Portfolio Table 101. Microvention Recent Development Table 102. Phenox GmbH Company Information Table 103. Phenox GmbH Business Overview Table 104. Phenox GmbH Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio Table 106. Phenox GmbH Recent Development Table 107. Accumedical Company Information Table 108. Accumedical Business Overview Table 109. Accumedical Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Accumedical Pipeline Embolization Device (PED) Product Portfolio Table 111. Accumedical Recent Development Table 112. ZYLOX-TONBRIDGE Company Information Table 113. ZYLOX-TONBRIDGE Business Overview Table 114. ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio Table 116. ZYLOX-TONBRIDGE Recent Development Table 117. Medtronic Company Information Table 118. Medtronic Business Overview Table 119. Medtronic Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Medtronic Pipeline Embolization Device (PED) Product Portfolio Table 121. Medtronic Recent Development Table 122. Johnson & Johnson Company Information Table 123. Johnson & Johnson Business Overview Table 124. Johnson & Johnson Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio Table 126. Johnson & Johnson Recent Development Table 127. Stryker Corporation Company Information Table 128. Stryker Corporation Business Overview Table 129. Stryker Corporation Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio Table 131. Stryker Corporation Recent Development Table 132. MicroPort Company Information Table 133. MicroPort Business Overview Table 134. MicroPort Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. MicroPort Pipeline Embolization Device (PED) Product Portfolio Table 136. MicroPort Recent Development Table 137. North America Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. North America Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 139. North America Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2026) Table 140. North America Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032) & (k units) Table 141. North America Pipeline Embolization Device (PED) Sales Market Share Forecast by Country (2027-2032) Table 142. North America Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Pipeline Embolization Device (PED) Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Pipeline Embolization Device (PED) Market Share by Country (2021-2026) Table 145. North America Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Pipeline Embolization Device (PED) Market Share Forecast by Country (2027-2032) Table 147. Europe Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Europe Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 149. Europe Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2026) Table 150. Europe Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032) & (k units) Table 151. Europe Pipeline Embolization Device (PED) Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Pipeline Embolization Device (PED) Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Pipeline Embolization Device (PED) Market Share by Country (2021-2026) Table 155. Europe Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Pipeline Embolization Device (PED) Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 159. Asia-Pacific Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032) & (k units) Table 161. Asia-Pacific Pipeline Embolization Device (PED) Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Pipeline Embolization Device (PED) Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Pipeline Embolization Device (PED) Market Share by Country (2021-2026) Table 165. Asia-Pacific Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Pipeline Embolization Device (PED) Market Share Forecast by Country (2027-2032) Table 167. Latin America Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Latin America Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 169. Latin America Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2026) Table 170. Latin America Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032) & (k units) Table 171. Latin America Pipeline Embolization Device (PED) Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Pipeline Embolization Device (PED) Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Pipeline Embolization Device (PED) Market Share by Country (2021-2026) Table 175. Latin America Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Pipeline Embolization Device (PED) Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 179. Middle East and Africa Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032) & (k units) Table 181. Middle East and Africa Pipeline Embolization Device (PED) Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Pipeline Embolization Device (PED) Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Pipeline Embolization Device (PED) Market Share by Country (2021-2026) Table 185. Middle East and Africa Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Pipeline Embolization Device (PED) Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Pipeline Embolization Device (PED) Distributors List Table 190. Pipeline Embolization Device (PED) Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Pipeline Embolization Device (PED) Image Figure 2. Global Pipeline Embolization Device (PED) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pipeline Embolization Device (PED) Market Size (2021-2032) & (US$ Million) Figure 4. Global Pipeline Embolization Device (PED) Sales (2021-2032) & (k units) Figure 5. 48 Alloy Wire Braided Image Figure 6. Global 48 Alloy Wire Braided Sales YoY Growth (2021-2032) & (k units) Figure 7. 64 Alloy Wire Braided Image Figure 8. Global 64 Alloy Wire Braided Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Pipeline Embolization Device (PED) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pipeline Embolization Device (PED) Market Share by Type 2025 VS 2032 Figure 13. North America Pipeline Embolization Device (PED) Sales Market Share in Volume by Type in 2025 Figure 14. North America Pipeline Embolization Device (PED) Sales Market Share in Value by Type in 2025 Figure 15. Europe Pipeline Embolization Device (PED) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pipeline Embolization Device (PED) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pipeline Embolization Device (PED) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pipeline Embolization Device (PED) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pipeline Embolization Device (PED) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pipeline Embolization Device (PED) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pipeline Embolization Device (PED) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pipeline Embolization Device (PED) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pipeline Embolization Device (PED) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Intracranial Aneurysm Treatment Image Figure 26. Global Intracranial Aneurysm Treatment Sales YoY Growth (2021-2032) & (k units) Figure 27. Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.) Image Figure 28. Global Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.) Sales YoY Growth (2021-2032) & (k units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Pipeline Embolization Device (PED) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pipeline Embolization Device (PED) Market Share by Application 2025 VS 2032 Figure 33. North America Pipeline Embolization Device (PED) Sales Market Share in Volume by Application in 2025 Figure 34. North America Pipeline Embolization Device (PED) Sales Market Share in Value by Application in 2025 Figure 35. Europe Pipeline Embolization Device (PED) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pipeline Embolization Device (PED) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pipeline Embolization Device (PED) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pipeline Embolization Device (PED) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pipeline Embolization Device (PED) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pipeline Embolization Device (PED) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pipeline Embolization Device (PED) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pipeline Embolization Device (PED) Sales Market Share in Value by Application in 2025 Figure 43. North America Pipeline Embolization Device (PED) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Pipeline Embolization Device (PED) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pipeline Embolization Device (PED) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pipeline Embolization Device (PED) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Pipeline Embolization Device (PED) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pipeline Embolization Device (PED) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pipeline Embolization Device (PED) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Pipeline Embolization Device (PED) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pipeline Embolization Device (PED) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pipeline Embolization Device (PED) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Pipeline Embolization Device (PED) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pipeline Embolization Device (PED) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pipeline Embolization Device (PED) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Pipeline Embolization Device (PED) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pipeline Embolization Device (PED) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pipeline Embolization Device (PED) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pipeline Embolization Device (PED) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 48 Alloy Wire Braided
  • 64 Alloy Wire Braided
  • Other
Applications
  • Intracranial Aneurysm Treatment
  • Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
  • Other
Companies covered
  • Ascendis Health
  • Balt Extrusion
  • Boston Scientific
  • Codman
  • Evasc
  • Microvention
  • Phenox GmbH
  • Accumedical
  • ZYLOX-TONBRIDGE
  • Medtronic
  • Johnson & Johnson
  • Stryker Corporation
  • MicroPort

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pipeline Embolization Device (PED) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pipeline Embolization Device (PED) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pipeline Embolization Device (PED) Market by Type
  6. 1.3.1 48 Alloy Wire Braided
  7. 1.3.2 64 Alloy Wire Braided
  8. 1.3.3 Other
  9. 1.4 Global Pipeline Embolization Device (PED) Market Size by Type
  10. 1.4.1 Global Pipeline Embolization Device (PED) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pipeline Embolization Device (PED) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pipeline Embolization Device (PED) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pipeline Embolization Device (PED) Industry Trends
  2. 2.2 Pipeline Embolization Device (PED) Industry Drivers
  3. 2.3 Pipeline Embolization Device (PED) Industry Opportunities and Challenges
  4. 2.4 Pipeline Embolization Device (PED) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pipeline Embolization Device (PED) Revenue (2021-2026)
  2. 3.2 Global Top Players by Pipeline Embolization Device (PED) Sales (2021-2026)
  3. 3.3 Global Top Players by Pipeline Embolization Device (PED) Price (2021-2026)
  4. 3.4 Global Pipeline Embolization Device (PED) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pipeline Embolization Device (PED) Major Company Production Sites & Headquarters
  6. 3.6 Global Pipeline Embolization Device (PED) Company, Product Type & Application
  7. 3.7 Global Pipeline Embolization Device (PED) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pipeline Embolization Device (PED) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pipeline Embolization Device (PED) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pipeline Embolization Device (PED) Tier 1, Tier 2, and Tier 3
4 Pipeline Embolization Device (PED) Regional Status and Outlook
  1. 4.1 Global Pipeline Embolization Device (PED) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pipeline Embolization Device (PED) Historic Market Size by Region
  3. 4.2.1 Global Pipeline Embolization Device (PED) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pipeline Embolization Device (PED) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pipeline Embolization Device (PED) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pipeline Embolization Device (PED) Forecasted Market Size by Region
  7. 4.3.1 Global Pipeline Embolization Device (PED) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pipeline Embolization Device (PED) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pipeline Embolization Device (PED) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pipeline Embolization Device (PED) by Application
  1. 5.1 Pipeline Embolization Device (PED) Market by Application
  2. 5.1.1 Intracranial Aneurysm Treatment
  3. 5.1.2 Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
  4. 5.1.3 Other
  5. 5.2 Global Pipeline Embolization Device (PED) Market Size by Application
  6. 5.2.1 Global Pipeline Embolization Device (PED) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pipeline Embolization Device (PED) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pipeline Embolization Device (PED) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ascendis Health
  2. 6.1.1 Ascendis Health Company Information
  3. 6.1.2 Ascendis Health Business Overview
  4. 6.1.3 Ascendis Health Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ascendis Health Pipeline Embolization Device (PED) Product Portfolio
  6. 6.1.5 Ascendis Health Recent Developments
  7. 6.2 Balt Extrusion
  8. 6.2.1 Balt Extrusion Company Information
  9. 6.2.2 Balt Extrusion Business Overview
  10. 6.2.3 Balt Extrusion Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio
  12. 6.2.5 Balt Extrusion Recent Developments
  13. 6.3 Boston Scientific
  14. 6.3.1 Boston Scientific Company Information
  15. 6.3.2 Boston Scientific Business Overview
  16. 6.3.3 Boston Scientific Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boston Scientific Pipeline Embolization Device (PED) Product Portfolio
  18. 6.3.5 Boston Scientific Recent Developments
  19. 6.4 Codman
  20. 6.4.1 Codman Company Information
  21. 6.4.2 Codman Business Overview
  22. 6.4.3 Codman Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Codman Pipeline Embolization Device (PED) Product Portfolio
  24. 6.4.5 Codman Recent Developments
  25. 6.5 Evasc
  26. 6.5.1 Evasc Company Information
  27. 6.5.2 Evasc Business Overview
  28. 6.5.3 Evasc Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Evasc Pipeline Embolization Device (PED) Product Portfolio
  30. 6.5.5 Evasc Recent Developments
  31. 6.6 Microvention
  32. 6.6.1 Microvention Company Information
  33. 6.6.2 Microvention Business Overview
  34. 6.6.3 Microvention Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Microvention Pipeline Embolization Device (PED) Product Portfolio
  36. 6.6.5 Microvention Recent Developments
  37. 6.7 Phenox GmbH
  38. 6.7.1 Phenox GmbH Company Information
  39. 6.7.2 Phenox GmbH Business Overview
  40. 6.7.3 Phenox GmbH Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio
  42. 6.7.5 Phenox GmbH Recent Developments
  43. 6.8 Accumedical
  44. 6.8.1 Accumedical Company Information
  45. 6.8.2 Accumedical Business Overview
  46. 6.8.3 Accumedical Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Accumedical Pipeline Embolization Device (PED) Product Portfolio
  48. 6.8.5 Accumedical Recent Developments
  49. 6.9 ZYLOX-TONBRIDGE
  50. 6.9.1 ZYLOX-TONBRIDGE Company Information
  51. 6.9.2 ZYLOX-TONBRIDGE Business Overview
  52. 6.9.3 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio
  54. 6.9.5 ZYLOX-TONBRIDGE Recent Developments
  55. 6.10 Medtronic
  56. 6.10.1 Medtronic Company Information
  57. 6.10.2 Medtronic Business Overview
  58. 6.10.3 Medtronic Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Medtronic Pipeline Embolization Device (PED) Product Portfolio
  60. 6.10.5 Medtronic Recent Developments
  61. 6.11 Johnson & Johnson
  62. 6.11.1 Johnson & Johnson Company Information
  63. 6.11.2 Johnson & Johnson Business Overview
  64. 6.11.3 Johnson & Johnson Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio
  66. 6.11.5 Johnson & Johnson Recent Developments
  67. 6.12 Stryker Corporation
  68. 6.12.1 Stryker Corporation Company Information
  69. 6.12.2 Stryker Corporation Business Overview
  70. 6.12.3 Stryker Corporation Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio
  72. 6.12.5 Stryker Corporation Recent Developments
  73. 6.13 MicroPort
  74. 6.13.1 MicroPort Company Information
  75. 6.13.2 MicroPort Business Overview
  76. 6.13.3 MicroPort Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 MicroPort Pipeline Embolization Device (PED) Product Portfolio
  78. 6.13.5 MicroPort Recent Developments
7 North America by Country
  1. 7.1 North America Pipeline Embolization Device (PED) Sales by Country
  2. 7.1.1 North America Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pipeline Embolization Device (PED) Sales by Country (2021-2026)
  4. 7.1.3 North America Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pipeline Embolization Device (PED) Market Size by Country
  6. 7.2.1 North America Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
  8. 7.2.3 North America Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pipeline Embolization Device (PED) Sales by Country
  2. 8.1.1 Europe Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pipeline Embolization Device (PED) Sales by Country (2021-2026)
  4. 8.1.3 Europe Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pipeline Embolization Device (PED) Market Size by Country
  6. 8.2.1 Europe Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pipeline Embolization Device (PED) Sales by Country
  2. 9.1.1 Asia-Pacific Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pipeline Embolization Device (PED) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pipeline Embolization Device (PED) Market Size by Country
  6. 9.2.1 Asia-Pacific Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pipeline Embolization Device (PED) Sales by Country
  2. 10.1.1 South America Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pipeline Embolization Device (PED) Sales by Country (2021-2026)
  4. 10.1.3 South America Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pipeline Embolization Device (PED) Market Size by Country
  6. 10.2.1 South America Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
  8. 10.2.3 South America Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pipeline Embolization Device (PED) Sales by Country
  2. 11.1.1 Middle East and Africa Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pipeline Embolization Device (PED) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pipeline Embolization Device (PED) Market Size by Country
  6. 11.2.1 Middle East and Africa Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pipeline Embolization Device (PED) Value Chain Analysis
  2. 12.1.1 Pipeline Embolization Device (PED) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pipeline Embolization Device (PED) Production Mode & Process
  7. 12.2 Pipeline Embolization Device (PED) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pipeline Embolization Device (PED) Distributors
  10. 12.2.3 Pipeline Embolization Device (PED) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research